WASHINGTON (Reuters) - The Supreme Court rejected two patents on a method for monitoring a patient's blood to determine the best dosage for a drug, a decision that may affect the profitability of personalized medicine.
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/bowY9NrVII0/us-mayo-prometheus-patent-idUSBRE82J18I20120321
internet business Current news latest news top news recent news save money
No comments:
Post a Comment